4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-17-037366
$CPIXCIK 0001087294operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:22 PM ET
Size
4.5 KB
Accession
0001209191-17-037366
Insider Transaction Report
Form 4
Griggs Jonathan
Director
Transactions
- Sale
Common Stock
2017-05-31$6.97/sh−8,000$55,760→ 10,803 total
Footnotes (1)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:22 PM ET
- Size
- 4.5 KB